1. Russian Federation Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Public Joint-Stock Company Pharmacy Chain 36.6

Public Joint-Stock Company Pharmacy Chain 36.6

APTK.ME
Public Joint-Stock Company Pharmacy Chain 36.6RU flagMoscow Stock Exchange
6.52
RUB
-0.05
- -
49.77BMarket Cap
Public Joint-Stock Company Pharmacy Chain 36.6
APTK.ME
(Moscow Stock Exchange)

Recent

price

6.52

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
170.19
169.12
118.23
94.52
17.52
28.38
40.09
18.31
18.8
7.33
5.77
5.78
7.74
153.13
Revenue per Share
- -
- -
- -
-7.58
-8.21
-7.71
-82.53
-0.11
-0.16
-8.15
-4.97
-9.67
-1.78
0.93
-0.12
0.03
-11.16
Basic EPS, GAAP
- -
- -
- -
-19.38
-7.12
4.52
-29.55
-1.03
-0.67
-3.43
-4.4
-4.22
-0.76
-0.78
0.29
0.73
-12.23
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
-36.43
-43.14
-50.93
-134.45
-6.35
-5.89
-13.17
-10.7
-21.54
-11.49
-7.39
-6.71
-6.69
-59.69
Book Value per Share
- -
- -
- -
-7.37
-8.14
-12.89
-84.55
-10.52
-13.25
-26.58
-13.95
-20.26
-6.67
-2.67
-2.56
-2.61
-23.31
Tangible Book Value per Share
- -
- -
- -
120
126
126
126
1,089
1,124
1,146
2,635
2,376
4,979
6,807
7,630
7,630
126
Basic Weighted Avg Shares
20,765
25,764
21,062
20,381
21,312
14,899
11,911
19,071
31,890
45,947
48,253
44,664
36,524
39,267
44,104
59,048
19,297
Sales/Revenue/Turnover
-6.5
0.74
4.47
6.45
8.73
-5.56
-20.75
-1.9
-0.99
-3.33
-7.61
-7.71
-5.88
2.66
2.86
8.12
0.32
Operating Margin (%)
500
531
481
477
451
263
229
163
424
1,043
1,497
5,482
5,151
5,341
5,807
5,789
381
Depreciation Expense
-2,980
-1,641
-359
-908
-1,034
-971
-10,400
-115
-178
-9,345
-13,097
-22,977
-8,855
6,351
-950
223
-1,406
Net Income, GAAP
- -
- -
83.47
3,107.69
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
45.74
25.81
Effective Tax Rate (%)
-14.35
-6.37
-1.71
-4.46
-4.85
-6.52
-87.31
-0.6
-0.56
-20.34
-27.14
-51.44
-24.24
16.17
-2.15
0.38
-7.29
Profit Margin (%)
-4,810
-2,732
275
1,881
-2,832
-2,928
-5,289
-5,589
-3,934
-14,763
-9,370
-25,741
-11,994
5,763
-15,394
-12,737
-2,141
Working Capital
530
799
4,649
5,771
1,574
2,523
6,425
7,747
12,315
17,129
28,356
32,325
29,749
35,338
15,426
22,168
5,346
LT Debt
5,565
4,903
3,994
4,313
4,198
3,674
-10,638
242
1,387
-531
-13,818
-36,808
-23,556
-5,704
-6,654
-6,431
2,748
Total Equity
- -
- -
1.42
-304.3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
9.91
0.3
Return on Invested Capital (%)
- -
- -
-12.01
-21.05
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-13.12
-12.26
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'12
Mar'13
Jun'13
ST Debt
8,387
4,842
6,813
LT Borrowings
2,514
5,536
5,341
LT Finance Leases
9
7
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
126
126
126
Market Capitalization
- -
3,697
2,571

Working Capital

FRC

•

in mil. unless spec.
Dec'12
Mar'13
Jun'13
Total Current Assets
12,909
12,356
11,754
Cash, Cash Equivalents & STI
838
436
719
Accounts Receivable, Net
4,257
4,491
4,348
Inventories
3,398
2,886
2,793
Total Current Liabilities
15,837
12,698
13,895
Payables & Accruals
- -
- -
- -
ST Debt
8,387
4,842
6,813
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
241.32%
13.58%
-3.35%
Free Cash Flow
-27.32%
-6.31%
147.55%
Net Income, GAAP
572.09%
-79.23%
-123.47%
Sales/Revenue/Turnover
18.44%
5.61%
33.88%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
44,104
2022
- -
- -
- -
- -
59,048
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-0.12
2022
- -
- -
- -
- -
0.03
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
FusionPharm, Inc. (FSPM)
Grupo International Inc. (GRPI)
Luyan Pharma Co.,Ltd. (002788.SZ)
LifeMD, Inc. (LFMDP)
Neuca S.a. (NEU.WA)
Welcia Holdings Co., Ltd. (WLCGF)
Business
Public Joint-Stock Company Pharmacy Chain 36.6, established in Moscow in 1991, functions as a prominent pharmaceutical retailer across the Russian Federation. Its extensive network of stores supplies a broad range of medicinal products, health, and beauty essentials. The enterprise connects with consumers primarily through its well-known 36.6 and Gorzdrav brand identities. Recognized among the top three pharmacy chains in Russia for market share and gross turnover as of 2024, the group also holds interests in pharmaceutical production.